Home/AXON Neuroscience/Michal Fresser
MF

Michal Fresser

Chief Executive Officer

AXON Neuroscience

AXON Neuroscience Pipeline

DrugIndicationPhase
AADvac1Alzheimer's DiseasePhase 2
AADvac2Alzheimer's DiseasePre-clinical